News & Analysis on Clinical Trial Services & Contract Research And Development
People on the Move
By Melissa Fassbender
- Last updated on
Dr. Chang Lee has been named vice president of consulting, APAC at Parexel. Lee previously led regulatory and clinical affairs at Capsugel, KV Pharmaceuticals, Morton Grove Pharmaceuticals, TAP Pharmaceutical Products Inc., Novartis OTC, and Igenix. He also served as a medical officer at the FDA’s Center for Drug Evaluation.
Lee told us his top priority will be to grow the company’s consulting services in China and Asia Pacific.
“The reform of the Chinese Food and Drug Administration (CFDA) has been driving significant changes in the pharmaceutical industry, positioning the Chinese market for new drug products to become the second-largest market in the world in the next few years, making it an exciting time to join Parexel and leverage the large opportunities to advance drug development in this region,” he added.